Targeting Key Enzymatic Snake Venom Proteins Using Repurposed Small Molecule Inhibitors: Emerging Adjuncts to Antivenom Therapy
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27136000 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Nisha Reghu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology, Amrita Vishwa Vidyapeetham, Amritapuri, Clappana PO., Kollam 690 525, Kerala, India. Hauptthemen laut MEDLINE: Antivenins, Snake Venoms, Snake Bites, Drug Repositioning. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health Research, Ministry of Health and Family Welfare, Indian Council of Medical Research, Government of India.
Abstract (Originalsprache)
Snakebite envenoming is a neglected tropical disease causing approximately 81,410–137,880 deaths globally each year and four-fold more disabilities than mortality rate. Despite the availability of antivenoms for treatment, several in vitro and in vivo preclinical studies have shown that their efficacy is limited by many factors including regional venom variation and poor neutralization of major venom toxins. To address these limitations, the potential of alternatives including aptamers, recombinant monoclonal antibodies, camelid antibodies, small molecule inhibitors, and natural product-based inhibitors targeting key venom proteins have been explored. Among these, small molecule inhibitors targeting key enzymatic snake venom proteins are emerging as adjuvants to antivenom treatment. Most of these small molecules are repurposed drugs with established safety, oral bioavailability, and lower cost compared to antivenoms. In this regard, this review tries to compile available information regarding the use of small molecule inhibitors to counteract envenomation with special emphasis on three major enzymatic snake venom protein families: phospholipase A2, snake venom metalloproteinases, and snake venom serine proteases. In vitro studies have shown that these small molecule inhibitors used either alone or in combination with antivenom can potentially reduce the adverse effects of venom-induced coagulopathy, neurotoxicity, tissue damage, and inflammation. However, critical gaps remain including limited human clinical trial data, uncertain efficacy across diverse venoms, and undefined dosing strategies. Overall, small molecules represent a mechanistically targeted and clinically promising adjunct to antivenom therapy, warranting further validation through randomized trials, pharmacokinetic studies, and development of field-applicable treatment protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biotechnology, Amrita Vishwa Vidyapeetham, Amritapuri, Clappana PO., Kollam 690 525, Kerala, India.
ORCID-Profile: Nisha Reghu, Muralidharan Vanuopadath
Förderung
- Department of Health Research, Ministry of Health and Family Welfare, Indian Council of Medical Research, Government of India
Zitieren
APA
Reghu, N., Kiruthika, S., Santhosh, A. K., Narayanan, A. L., Geetha, K. G., Sidheek, N., Danthuluri, S. S., Nair, B. G., & Vanuopadath, M. (2026). Targeting Key Enzymatic Snake Venom Proteins Using Repurposed Small Molecule Inhibitors: Emerging Adjuncts to Antivenom Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27136000
Vancouver
Reghu N, Kiruthika S, Santhosh AK, Narayanan AL, Geetha KG, Sidheek N, et al. Targeting Key Enzymatic Snake Venom Proteins Using Repurposed Small Molecule Inhibitors: Emerging Adjuncts to Antivenom Therapy. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27136000
BibTeX
@article{Reghu2026,
author = {Reghu, Nisha and Kiruthika, S and Santhosh, Anand Krishna and Narayanan, Aparna Lakshmi and Geetha, Krishna Geetha and Sidheek, Noureen and Danthuluri, Sai Sahithi and Nair, Bipin Gopalakrishnan and Vanuopadath, Muralidharan},
title = {Targeting Key Enzymatic Snake Venom Proteins Using Repurposed Small Molecule Inhibitors: Emerging Adjuncts to Antivenom Therapy},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27136000}
}
EUVIMED